Cancer Cause and Prevention Research in Florida
Cancer Cause and Prevention Research (93.393) awarded $99.7 million to recipients in Florida in 72 grants from fiscal 2021 to 2025, 2.8% of the program's national total. H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received the most, $44.8 million.
- Awarded in Florida$99.7 million
- Awards72
- Share of the program2.8%
- Rank among states11th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 25 | $12.7 million |
| FY 2022 | 34 | $16.1 million |
| FY 2023 | 42 | $19.3 million |
| FY 2024 | 42 | $20.9 million |
| FY 2025 | 41 | $30.7 million |
Recipients in Florida
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. | Nonprofits | 29 | $44.8 million |
| University of Florida | Colleges and universities | 16 | $20.5 million |
| University of Miami | Colleges and universities | 6 | $11.1 million |
| University of Miami | Colleges and universities | 7 | $8.8 million |
| Mayo Clinic Jacksonville (a Nonprofit Corporation) | Nonprofits | 5 | $7.5 million |
| Adventist Health System/Sunbelt Inc | Nonprofits | 1 | $3.7 million |
| University of South Florida | Colleges and universities | 5 | $2.4 million |
| Florida International University | Colleges and universities | 2 | $560,972 |
| Arnold Consultancy & Technology, LLC | Small businesses | 1 | $357,371 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Florida?
$99.7 million from fiscal 2021 to 2025, across 72 awards. Florida ranks 11th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Florida?
The largest recipient is H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., with $44.8 million in 29 awards. Next are University of Florida and University of Miami.
Can organizations in Florida apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Florida
- Grants to States for Medicaid
- Education Stabilization Fund
- Highway Planning and Construction
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii
- Title I Grants to Local Educational Agencies
- Child Care and Development Block Grant
- Special Education Grants to States
- Children's Health Insurance Program